Pure Biologics SA (PQB) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Pba-0111 | Triple Negative Breast Cancer, Head And Neck Squamous Cell Carcinoma, Soft Tissue Sarcoma Adult | earlyPhase1 | Recruiting | A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors | Nov 19, 2024 | ― |
| Pba-0405 | Triple Negative Breast Cancer, Head And Neck Squamous Cell Carcinoma, Soft Tissue Sarcoma Adult | earlyPhase1 | Completed | A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors | Feb 15, 2024 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Pba-0111 | earlyPhase1 | Triple Negative Breast Cancer, Head And Neck Squamous Cell Carcinoma, Soft Tissue Sarcoma Adult | Recruiting | A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors | Nov 19, 2024 | ― |
| Pba-0405 | earlyPhase1 | Triple Negative Breast Cancer, Head And Neck Squamous Cell Carcinoma, Soft Tissue Sarcoma Adult | Completed | A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors | Feb 15, 2024 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Pure Biologics SA (DE:PQB) have in its pipeline
Pure Biologics SA DE:PQB is currently developing the following drugs: Pba-0111, Pba-0405. These drug candidates are in various stages of clinical development as the company works toward FDA approval.